Coave Therapeutics

Coave Therapeutics is a clinical-stage biotech company focused on developing life-changing gene therapies in rare ocular and CNS (Central Nervous System) diseases.

Coave’s next-generation AAV-Ligand Conjugate (‘ALIGATER’) platform enables targeted delivery and enhanced gene transduction to improve the effectiveness of advanced gene therapies for rare diseases.

Bruno Montanari

Managed by

Bruno Montanari


We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top